Thrombolysis remains the most commonly used reperfusion therapy in acute myocardial infarction (AMI) in the United Kingdom, Europe and the developing world. Recent evidence suggests that thrombolysis may be equivalent to primary percutaneous...
Thrombolysis remains the most commonly used reperfusion therapy in acute myocardial infarction (AMI) in the United Kingdom, Europe and the developing world. Recent evidence suggests that thrombolysis may be equivalent to primary percutaneous...
Thrombolysis remains the most...